Skip to content

Clinical trials

Phase 1 Parkinson Disease trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Phase 1 Country / region: Australia Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20161
20171
20211
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Completed3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Collaborative Medicinal Development Pty Limited1
Cyto Therapeutics Pty Limited1
Gain Therapeutics, Inc.1
Longevity Biotech Australia Pty Ltd (subsidiary)1
Luye Pharma Group Ltd.1
Mission Therapeutics1
Royal Brisbane and Women's Hospital1
Serina Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease8
Hypotension, Orthostatic1
Lymphoma, Follicular1
Multiple System Atrophy1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.